Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome
about
Metabolomics and Its Application to Acute Lung DiseasesAlterations in the human lung proteome with lipopolysaccharide.Does activation of the FcgammaRIIa play a role in the pathogenesis of the acute lung injury/acute respiratory distress syndrome?Safety of prolonged, repeated administration of a pulmonary formulation of tissue plasminogen activator in miceAntithrombin attenuates vascular leakage via inhibiting neutrophil activation in acute lung injuryAssessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography.Coagulopathy as a prognostic factor of acute lung injury in childrenRecent advances in genetic predisposition to clinical acute lung injury.Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in mice.Protective mechanisms of activated protein C in severe inflammatory disorders.Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndromeImpact of thrombosis on pulmonary endothelial injury and repair following sepsis.A Missense Genetic Variant in LRRC16A/CARMIL1 Improves Acute Respiratory Distress Syndrome Survival by Attenuating Platelet Count Decline.Unfractionated heparin ameliorates lipopolysaccharide-induced lung inflammation by downregulating nuclear factor-κB signaling pathway.Fibrinolysis in trauma: a review.Anticoagulant therapy in acute respiratory distress syndrome.Diagnostic indicator of acute lung injury for pediatric critically ill patients at a tertiary pediatric hospital.Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
P2860
Q26765930-D1E5BD72-C5AD-41F4-A547-9EE61791455FQ33443562-598794D3-584F-4E6F-87FD-5B7E2B8087D6Q33610593-1350458C-B8A9-45B7-B477-B29DF1BEBDFAQ33653355-D106CED8-57B9-465A-B7F2-B3B7AC0F1559Q33776326-B53C3A92-26B1-4DC0-B584-8F7DFBC05C36Q35755770-0503A94A-B8E1-4F22-9C58-86C2417F90ADQ36472995-1DAA9BE7-8328-4CBF-BDA8-28173832A7CDQ37190198-57A6A32B-CE06-4976-B7F4-D3E74BA91371Q37426825-47719AF0-77E2-429E-8AC0-89510082E5B3Q37494702-B2770041-19A6-477F-BCC0-D6CA6AB79558Q37852747-6B977258-9B93-48EA-859F-1FF1D8DA7459Q39107051-D7A040A7-15C7-4FEB-9CAC-EFBD82FA0937Q39262183-A692414A-C2DE-4A28-804F-39A6AFB4E8ADQ43580550-8038C2DA-8C55-499D-8DF4-49ED95577DB9Q47251777-F2B74653-3D9F-47D7-AB96-E96B676AA50BQ50072766-143BECEF-3760-4472-9EFF-46CCFD2B9AAEQ54259885-F7790904-F87D-4C04-938D-2711853942CDQ58735023-44A22142-957A-4292-8E5A-1129D421B588
P2860
Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Emerging role of anticoagulant ...... respiratory distress syndrome
@en
type
label
Emerging role of anticoagulant ...... respiratory distress syndrome
@en
prefLabel
Emerging role of anticoagulant ...... respiratory distress syndrome
@en
P2860
P356
P1433
P1476
Emerging role of anticoagulant ...... respiratory distress syndrome
@en
P2093
Kathleen A Stringer
Robert MacLaren
P2860
P304
P356
10.1592/PHCO.27.6.860
P407
P577
2007-06-01T00:00:00Z